Kyntra Bio, Inc. (KYNB)
$6.11+2.52%Close
SELLCRISIS · day 17
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $25M
- Beta
- 1.05
- P/E (TTM)
- 0.10
- Short % float
- 2.81%
- Days to cover
- 3.7
- SI change
- -0.7%
- 1W
- -3.17%
- 1M
- -23.43%
- vs SPY 1W
- -4.33%
- vs SPY 1M
- -26.43%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on KYNB?
- LOPJLB’s latest quantitative signal on Kyntra Bio, Inc. (KYNB) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is KYNB in?
- Kyntra Bio, Inc. (KYNB) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Kyntra Bio, Inc. (KYNB) do?
- Kyntra Bio, Inc. functions as a biopharmaceutical enterprise, encompassing the entire process from the initial discovery and rigorous development of innovative treatments to their ultimate market introduction. The company's scientific focus delves into the complex biology of hypoxia-inducible factors (HIF) and connective tissue growth factors (CTGF). Through this research, Kyntra Bio strives to…